Literature DB >> 12921879

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

Sylvia Cruchet1, Maria Clara Obregon, Gabriela Salazar, Eric Diaz, Martin Gotteland.   

Abstract

OBJECTIVES: Dietary components such as vegetable or probiotic microorganisms have been proposed as an alternative solution to decrease Helicobacter pylori colonization in at-risk populations. Some strains of lactic acid bacteria have been shown to exert bacteriostatic or bactericidal effects against H. pylori in in vitro and in vivo models of infection by this pathogen. We investigated whether regular ingestion of a dietary product containing Lactobacillus johnsonii La1 or L. paracasei ST11 would interfere with H. pylori colonization in children.
METHODS: A double blind, randomized, controlled clinical trial was carried out in school children from a low socioeconomic area of Santiago. Subjects were 326 asymptomatic children (9.7 +/- 2.6 y) screened for H. pylori by the (13)C-urea breath test; H. pylori-colonized subjects were distributed into five groups to receive a product containing live La1 or ST11 (groups 1 and 3), heat-killed La1 or ST11 (groups 2 and 4), or vehicle (group 5) everyday for 4 wk. A second (13)C-urea breath test was carried out at the end of this period. Differences in delta(13)CO(2) above baseline values before (DOB1) and after (DOB2) probiotic treatment were evaluated.
RESULTS: A high prevalence of H. pylori colonization, 77.3%, was observed in our population. A moderate but significant difference (DOB2 - DOB1) was detected in children receiving live La1 (-7.64 per thousand; 95% confidence interval, -14.23 to -1.03), whereas no differences were observed in the other groups. The magnitude of the decrease in DOB values induced by La1 ingestion correlated with the basal values of DOB before treatment (r = 0.48, P = 0.0074).
CONCLUSIONS: Regular ingestion of a product containing Lactobacillus La1 may represent an interesting alternative to modulate H. pylori colonization in children infected by this pathogen.

Entities:  

Mesh:

Year:  2003        PMID: 12921879     DOI: 10.1016/s0899-9007(03)00109-6

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  36 in total

1.  Characterization and Antibacterial Activity Against Helicobacter pylori of Lactic Acid Bacteria Isolated from Thai Fermented Rice Noodle.

Authors:  Sujitra Techo; Wonnop Visessanguan; Ratha-Korn Vilaichone; Somboon Tanasupawat
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

2.  Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.

Authors:  Jeremy A Peña; Arlin B Rogers; Zhongming Ge; Vivian Ng; Sandra Y Li; James G Fox; James Versalovic
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

4.  Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.

Authors:  Lynne V McFarland; Ying Huang; Lin Wang; Peter Malfertheiner
Journal:  United European Gastroenterol J       Date:  2015-11-13       Impact factor: 4.623

Review 5.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

Review 6.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

Review 7.  Probiotics for the treatment of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; John Frederick Osborn; Enea Bonci; Sara Romaggioli; Rossella Baldini; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

8.  Impact of neonatal antibiotic treatment on the biodiversity of the murine intestinal Lactobacillus community.

Authors:  Jing Yuan; Hong Wei; Benhua Zeng; Huan Tang; Wenxia Li; Zhixue Zhang
Journal:  Curr Microbiol       Date:  2009-09-19       Impact factor: 2.188

9.  The probiotic Lactobacillus johnsonii NCC 533 produces high-molecular-mass inulin from sucrose by using an inulosucrase enzyme.

Authors:  Munir A Anwar; Slavko Kralj; Marc J E C van der Maarel; Lubbert Dijkhuizen
Journal:  Appl Environ Microbiol       Date:  2008-04-11       Impact factor: 4.792

10.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.